Case number 1:24-cv-01068
Astellas Pharma Inc. et al v. Lupin Ltd. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| May 16, 2025 | N/A | Minute Entry for proceedings held before Judge Joseph F. Bataillon - Markman Hearing held on 5/16/2025. Counsel for Plaintiff: Daniel M. Silver, Bryan S. Hales, and Tera Stone. Counsel for Defendants: Pilar Gabrielle Kraman, Alexis Stombaugh, Michael J. Gaertner, David B. Abramowitz, John C. Phillips, Jr., William R. Zimmerman, Andrea L. Cheek, Cortlan Hitch, and Sri Sankaran. (Court Reporter Stacy Ingram.) Associated Cases: 1:20-cv-01589-JFB-EGT et al.(mpb) (Entered: 05/16/2025) (0) |
| May 5, 2025 | 38 | NOTICE of Change of Address by John C. Phillips, Jr (Phillips, John) (Entered: 05/05/2025) (2) |
| Apr 14, 2025 | N/A | Pro Hac Vice Attorney Ashley Ross, Bryan S. Hales for Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., and Astellas Pharma Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 20-1589, 24-939, 24-940, 24-1068, 24-1069, 24-1084-JFB-EGT(cdd) (Entered: 04/14/2025) (0) |
| Apr 11, 2025 | N/A | Pro Hac Vice Attorney Jeanna M. Wacker for Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., and Astellas Pharma Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:20-cv-01589-JFB-EGT, 24-939, 24-940, 24-1068, 24-1069, & 24-1084.(cdd) (Entered: 04/11/2025) (0) |
| Feb 14, 2025 | 37 | ORAL ORDER - Plaintiffs' Motion to Seal and to Redact Portions of the January 16, 2025 Discovery Dispute Transcript (D.I. 669 in 20-1589-JFB-EGT, D.I. 141 in 23-486-JFB-EGT, D.I. 70 in 23-689-JFB-EGT, D.I. 420 in 23-819-JFB-EGT, D.I. 31 in 24-939-JFB-EGT, D.I. 30 in 24-940-JFB-EGT, D.I. 27 in 24-1068-JFB-EGT, D.I. 29 in 24-1069-JFB-EGT, D.I. 31 in 24-1084-JFB-EGT) is DENIED. The teleconference was open to the public and Plaintiffs did not request that the teleconference be sealed at any point. Plaintiffs also did not inquire as to whether any members of the public were on the line before stating that which they now seek to keep confidential. The Court is also not persuaded that the information sought to be redacted would work a clearly defined and serious competitive injury to Plaintiffs. See In re Avandia Marketing, Sales Practices & Products Liability Litigation, 924 F.3d 662, 672-73 (3d Cir. 2019). Indeed, Plaintiffs have not even attempted to make the requisite showing of harm with specificity, instead relying on broad and generic allegations of harm. More is needed to overcome the right of public access to judicial proceedings and records. ORDERED by Judge Eleanor G. Tennyson on 2/14/2025. Associated Cases: 1:20-cv-01589-JFB-EGT et al. (lah) (Entered: 02/14/2025) (0) |
| Feb 5, 2025 | N/A | Case associated with lead case 20-1589. ALL FUTURE FILINGS SHALL BE MADE IN LEAD CASE ONLY. (lah) (Entered: 02/05/2025) (0) |
| Feb 3, 2025 | 36 | NOTICE OF SERVICE of Lupin Ltd. and Lupin Pharmaceuticals, Inc.'s Third Supplemental Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) filed by Lupin Ltd., Lupin Pharmaceuticals, Inc..(Haney, Megan) (Entered: 02/03/2025) (3) |
| Feb 3, 2025 | 35 | NOTICE OF SERVICE of (1) Plaintiffs' Amended Rule 26(a)(1) Initial Disclosures for Litigation Involving U.S. Patent Nos. 10,842,780, 11,707,451, 12,059,409, and 12,097,189, (2) Plaintiffs' Third Supplemental Objections and Responses to Defendants' Joint Interrogatories Nos. 4-5, (3) Plaintiffs' Initial Infringement Charts, and (4) Plaintiffs' Supplemental Infringement Charts filed by Astellas Pharma Inc., Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc..(Silver, Daniel) (Entered: 02/03/2025) (6) |
| Jan 31, 2025 | N/A | Pro Hac Vice Attorney Joseph R. Re for Lupin Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (oam) (Entered: 01/31/2025) (0) |
| Jan 30, 2025 | 34 | REDACTED VERSION of (420 in 1:23-cv-00819-JFB-EGT, 141 in 1:23-cv-00486-JFB-EGT, 31 in 1:24-cv-01084-JFB-EGT, 31 in 1:24-cv-00939-JFB-EGT, 29 in 1:24-cv-01069-JFB-EGT, 30 in 1:24-cv-00940-JFB-EGT, 669 in 1:20-cv-01589-JFB-EGT, 27 in 1:24-cv-01068-JFB-EGT, 70 in 1:23-cv-00689-JFB-EGT) Unopposed MOTION to Redact (29 in 1:24-cv-01084-JFB-EGT) Transcript,, (27 in 1:24-cv-01069-JFB-EGT) Transcript,, (25 in 1:24-cv-01068-JFB-EGT) Transcript,, (665 in 1:20-cv-01589-JFB-EGT) Transcript,, (28 in 1:24-cv-00940-JFB-EGT) Transcript,, (41 by Astellas Pharma Inc., Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc.. (Joyce, Alexandra) (Entered: 01/30/2025) (30) |
| Jan 29, 2025 | 33 | SUPPLEMENTAL SCHEDULING ORDER - Joinder of Parties due by 4/4/2025. Amended Pleadings due by 4/4/2025. Fact Discovery completed by 5/19/2025. Opening Expert Reports due by 6/13/2025. Rebuttal Expert Reports due by 7/11/2025. Reply Expert Reports due by 8/4/2025. Expert Discovery due by 9/5/2025. Dispositive Motions due by 9/19/2025. Answering Brief due 10/17/2025. Reply Brief due 10/31/2025. Claim Construction Opening Brief due by 3/11/2025. Claim Construction Answering Brief due by 4/1/2025. Claim Construction Reply Brief due by 4/15/2025. Joint Claim Construction Brief due by 5/2/2025. Pretrial Order due by 1/19/2026. A Markman Hearing is set for 5/16/2025 at 09:00 AM in Courtroom 6A before Judge Joseph F. Bataillon. A Final Pretrial Conference is set for 1/26/2026 at 09:00 AM in Courtroom 2B before Judge Eleanor G. Tennyson. A 7-day Jury Trial is set for 2/9/2026 at 09:30 AM, with the subsequent trial days beginning at 09:00 AM, in a Courtroom to be determined before Judge Joseph F. Bataillon. Signed by Judge Eleanor G. Tennyson on 1/29/2025. Associated Cases: 1:20-cv-01589-JFB-EGT et al. (lah) (Entered: 01/29/2025) (17) |
| Jan 28, 2025 | 32 | PROPOSED ORDER Supplemental Scheduling Order re (32 in 1:24-cv-00940-JFB-EGT, 678 in 1:20-cv-01589-JFB-EGT, 33 in 1:24-cv-00939-JFB-EGT, 31 in 1:24-cv-01069-JFB-EGT, 422 in 1:23-cv-00819-JFB-EGT, 29 in 1:24-cv-01068-JFB-EGT) Oral Order,,,,, by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Joyce, Alexandra) (Entered: 01/28/2025) (17) |
| Jan 28, 2025 | 31 | Pro Hac Vice Fee - Credit Card Payment received for Joseh R. Re. ( re 30 MOTION for Pro Hac Vice Appearance of Attorney Joseph R. Re )( Payment of $ 50, receipt number ADEDC-4601119).(Haney, Megan) (Entered: 01/28/2025) (0) |
| Jan 28, 2025 | N/A | SO ORDERED, re (423 in 1:23-cv-00819-JFB-EGT, 34 in 1:24-cv-00939-JFB-EGT, 679 in 1:20-cv-01589-JFB-EGT, 30 in 1:24-cv-01068-JFB-EGT) MOTION for Pro Hac Vice Appearance of Attorney Joseph R. Re, filed by Lupin Ltd., Lupin Pharmaceuticals, Inc. ORDERED by Judge Eleanor G. Tennyson on 1/28/2025. Associated Cases: 1:20-cv-01589-JFB-EGT, 1:23-cv-00819-JFB-EGT, 1:24-cv-00939-JFB-EGT, 1:24-cv-01068-JFB-EGT(lah) (Entered: 01/28/2025) (0) |
| Jan 28, 2025 | 30 | MOTION for Pro Hac Vice Appearance of Attorney Joseph R. Re - filed by Lupin Ltd., Lupin Pharmaceuticals, Inc.. (Attachments: # 1 Certification of Joseph R. Re)Motions referred to Eleanor G. Tennyson.(Haney, Megan) (Entered: 01/28/2025) (0) |
| Jan 28, 2025 | 29 | ORAL ORDER - IT IS HEREBY ORDERED that, by close of business TODAY, the parties are to submit a proposed form of scheduling order without disputes or arguments in footnotes and consistent with the following rulings. The Court is adopting Plaintiffs' proposed dates for Paragraphs 7(c) & (d) (final non-infringement and validity contentions due by May 19, 2025), 8(a) (fact discovery due by May 19, 2025) and 8(g)(i) (opening expert reports due by June 13, 2025). The Court is adopting Defendants' proposed dates for Paragraphs 2 (deadline to join parties / amend pleadings is April 4, 2025) and 14(a) (dispositive motions and Daubert due by September 19, 2025, opposition due by October 17, 2025 and replies due by October 31, 2025). The Court is rejecting Plaintiffs' proposals in Paragraph 2 (requiring good cause to amend), Paragraph 3(d) (requiring good cause to re-depose), Paragraphs 7(d), 8(g)(ii) and 14(a) (explicitly limiting scope of contentions, expert reports and dispositive motions), as well as in Paragraph 12 (requiring single joint claim construction brief across all cases). The Court is adopting Defendants' proposal in Paragraph 3(d). Each side may have five (5) additional common requests for production (Paragraph 8(c)) and five (5) additional common and individual interrogatories (Paragraphs 8(e)(i) and (ii)). ORDERED by Judge Eleanor G. Tennyson on 1/28/2025. Associated Cases: 1:20-cv-01589-JFB-EGT et al. (lah) (Entered: 01/28/2025) (0) |
| Jan 24, 2025 | 28 | PROPOSED ORDER Supplemental Scheduling Order [with bracketed disputes] by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Joyce, Alexandra) (Entered: 01/24/2025) (21) |
| Jan 23, 2025 | 27 | [SEALED] Unopposed MOTION to Redact (29 in 1:24-cv-01084-JFB-EGT) Transcript,, (27 in 1:24-cv-01069-JFB-EGT) Transcript,, (25 in 1:24-cv-01068-JFB-EGT) Transcript,, (665 in 1:20-cv-01589-JFB-EGT) Transcript,, (28 in 1:24-cv-00940-JFB-EGT) Transcript,, (418 in 1:23-cv-00819-JFB-EGT) Transcript,, (68 in 1:23-cv-00689-JFB-EGT) Transcript,, (29 in 1:24-cv-00939-JFB-EGT) Transcript,, (139 in 1:23-cv-00486-JFB-EGT) Transcript,, - filed by Astellas Pharma Inc., Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Text of Proposed Order, # 4 Certificate of Service)Motions referred to Eleanor G. Tennyson.(Silver, Daniel) (Entered: 01/23/2025) (0) |
| Jan 23, 2025 | 26 | NOTICE of Intent to Request Redaction by Daniel M. Silver re (29 in 1:24-cv-01084-JFB-EGT) Transcript,, (27 in 1:24-cv-01069-JFB-EGT) Transcript,, (25 in 1:24-cv-01068-JFB-EGT) Transcript,, (665 in 1:20-cv-01589-JFB-EGT) Transcript,, (28 in 1:24-cv-00940-JFB-EGT) Transcript,, (418 in 1:23-cv-00819-JFB-EGT) Transcript,, (68 in 1:23-cv-00689-JFB-EGT) Transcript,, (29 in 1:24-cv-00939-JFB-EGT) Transcript,, (139 in 1:23-cv-00486-JFB-EGT) Transcript,, (Silver, Daniel) (Entered: 01/23/2025) (4) |
| Jan 23, 2025 | 25 | Official Transcript of Teleconference held on 01/16/25 before Judge Eleanor G. Tennyson. Court Reporter Heather M. Triozzi,Email: Heather_Triozzi@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 2/13/2025. Redacted Transcript Deadline set for 2/24/2025. Release of Transcript Restriction set for 4/23/2025. (Triozzi, Heather) (Entered: 01/23/2025) (45) |
| Jan 23, 2025 | N/A | SO ORDERED, re (D.I. 24 in 1:24-cv-01068-JFB-EGT, D.I. 27 in 1:24-cv-00940-JFB-EGT, D.I. 26 in 1:24-cv-01069-JFB-EGT, D.I. 664 in 1:20-cv-01589-JFB-EGT, D.I. 417 in 1:23-cv-00819-JFB-EGT, D.I. 28 in 1:24-cv-00939-JFB-EGT) STIPULATION and Proposed Order to Extend Time. Revised Proposed Scheduling Orders due by January 24, 2025. Signed by Judge Eleanor G. Tennyson on 1/23/2025. Associated Cases: 1:20-cv-01589-JFB-EGT et al.(lah) (Entered: 01/23/2025) (0) |
| Jan 22, 2025 | 24 | STIPULATION TO EXTEND TIME the deadline for the parties to submit revised case schedules to January 24, 2025 - filed by Astellas Pharma Inc., Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc.. (Silver, Daniel) (Entered: 01/22/2025) (4) |
| Jan 17, 2025 | 23 | NOTICE OF SERVICE of Plaintiffs' First Amended Initial Disclosures Identifying Defendants' Accused Products and Plaintiffs' Asserted Patents filed by Astellas Pharma Inc., Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc..(Silver, Daniel) (Entered: 01/17/2025) (5) |
| Jan 16, 2025 | N/A | Minute Entry for proceedings held before Judge Eleanor G. Tennyson - Telephonic Scheduling Conference held on 1/16/2025. The Court ordered the parties to submit a proposed scheduling order consistent with the dates provided at the conference by 1/22/2025. The parties are to use Court's form scheduling order, which is posted at http://www.ded.uscourts.gov (see Chambers, Magistrate Judge Tennyson, Forms). (Court Reporter Heather Triozzi.) Associated Cases: 1:20-cv-01589-JFB-EGT et al. (lah) (Entered: 01/16/2025) (0) |
| Jan 13, 2025 | 22 | ORAL ORDER - IT IS HEREBY ORDERED that a Telephonic Scheduling Conference is set for 1/16/2025 at 11:00 AM before Judge Eleanor G. Tennyson. Counsel shall provide a dial-in number for the teleconference by emailing egt_civil@ded.uscourts.gov. ORDERED by Judge Eleanor G. Tennyson on 1/13/2025. Associated Cases: 1:20-cv-01589-JFB-EGT et al. (lah) (Entered: 01/13/2025) (0) |
| Jan 7, 2025 | 21 | Letter to The Honorable Joseph F. Bataillon and The Honorable Eleanor G. Tennyson from Astellas, Zydus, and Lupin regarding Case Schedule - re (19 in 1:24-cv-01068-JFB-EGT, 20 in 1:24-cv-00940-JFB-EGT, 17 in 1:24-cv-01069-JFB-EGT, 24 in 1:24-cv-00939-JFB-EGT) Oral Order,,,,, (652 in 1:20-cv-01589-JFB-EGT) Order,,,,. (Attachments: # 1 Attachment A (Schedule))(Silver, Daniel) (Entered: 01/07/2025) (0) |
| Dec 30, 2024 | 20 | ANSWER to 15 Answer to Complaint, Counterclaim by Astellas Pharma Inc., Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc..(Joyce, Alexandra) (Entered: 12/30/2024) (6) |
| Dec 18, 2024 | N/A | Pro Hac Vice Attorney Michael DelRossi for Astellas Ireland Co., Ltd.,Michael DelRossi for Astellas Pharma Global Development, Inc.,Michael DelRossi for Astellas Pharma Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (scs) (Entered: 12/18/2024) (0) |
| Dec 17, 2024 | N/A | Pro Hac Vice Attorney Andrea L. Cheek for Lupin Ltd.,Andrea L. Cheek for Lupin Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (scs) (Entered: 12/17/2024) (0) |
| Dec 16, 2024 | 19 | ORAL ORDER - IT IS HEREBY ORDERED that, within twenty-one (21) days from the date of this Order, the parties shall meet and confer and submit a proposed scheduling order that is consistent with the guidance set forth in the Memorandum Order issued today in the related case Astellas Pharma Inc. et al. v. Sandoz Inc. et al., C.A. No. 20-1589-JFB (D.I. 652) and which includes a proposal for the length and timing of trial. In connection with this submission, the parties shall also provide their positions on coordination of these cases with currently pending actions involving Ascent Pharmaceuticals and MSN Pharmaceuticals (e.g., C.A. No. 24-1084-JFB-EGT). The parties are to use the Court's form scheduling order, which is posted at http://www.ded.uscourts.gov (see Chambers, Magistrate Judge Tennyson, Forms). If there are deviations from the form order or disputes that the Court needs to address, the parties shall direct the Court to the paragraph numbers in which those appear in a cover letter accompanying the proposed schedule. ORDERED by Judge Eleanor G. Tennyson on 12/16/2024. Associated Cases: 1:24-cv-00939-JFB-EGT, 1:24-cv-00940-JFB-EGT, 1:24-cv-01068-JFB-EGT, 1:24-cv-01069-JFB-EGT, 1:24-cv-01084-JFB-EGT (lah) (Entered: 12/16/2024) (0) |
| Dec 16, 2024 | N/A | Pro Hac Vice Attorney Jared C. Bunker,William R. Zimmerman for Lupin Ltd.,Jared C. Bunker,William R. Zimmerman for Lupin Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (scs) (Entered: 12/16/2024) (0) |
| Dec 16, 2024 | N/A | Pro Hac Vice Attorney Carol M. Pitzel Cruz for Lupin Ltd., Lupin Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (scs) (Entered: 12/16/2024) (0) |
| Dec 16, 2024 | N/A | SO ORDERED, re 17 MOTION for Pro Hac Vice Appearance of Attorney William R. Zimmerman, Andrea L. Cheek, Carol Pitzel Cruz and Jared C. Bunker, filed by Lupin Ltd., Lupin Pharmaceuticals, Inc. ORDERED by Judge Eleanor G. Tennyson on 12/16/2024. (lah) (Entered: 12/16/2024) (0) |
| Dec 16, 2024 | 18 | Pro Hac Vice Fee - Credit Card Payment received for William R. Zimmerman, Andrea L. Cheek, Carol Pitzel Cruz, and Jared C. Bunker. ( re 17 MOTION for Pro Hac Vice Appearance of Attorney William R. Zimmerman, Andrea L. Cheek, Carol Pitzel Cruz and Jared C. Bunker )( Payment of $ 200, receipt number ADEDC-4570849).(Haney, Megan) (Entered: 12/16/2024) (0) |
| Dec 16, 2024 | 17 | MOTION for Pro Hac Vice Appearance of Attorney William R. Zimmerman, Andrea L. Cheek, Carol Pitzel Cruz and Jared C. Bunker - filed by Lupin Ltd., Lupin Pharmaceuticals, Inc.. (Attachments: # 1 Certification of William R. Zimmerman, # 2 Certification of Andrea L. Cheek, # 3 Certification of Carol Pitzel Cruz, # 4 Certification of Jared C. Bunker)Motions referred to Eleanor G. Tennyson.(Haney, Megan) (Entered: 12/16/2024) (0) |
| Dec 9, 2024 | 16 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Lupin Ltd. for Lupin Pharmaceuticals, Inc. filed by Lupin Ltd., Lupin Pharmaceuticals, Inc.. (Phillips, John) (Entered: 12/09/2024) (3) |
| Dec 9, 2024 | 15 | ANSWER to 1 Complaint, Affirmative Defenses, COUNTERCLAIM against All Plaintiffs by Lupin Pharmaceuticals, Inc., Lupin Ltd..(Phillips, John) (Entered: 12/09/2024) (23) |
| Dec 5, 2024 | N/A | SO ORDERED, re (D.I. 13 in 1:24-cv-01069-JFB-EGT, D.I. 13 in 1:24-cv-01068-JFB-EGT, D.I. 18 in 1:24-cv-00940-JFB-EGT, D.I. 20 in 1:24-cv-01084-JFB-EGT, D.I. 22 in 1:24-cv-00939-JFB-EGT) MOTION for Pro Hac Vice Appearance of Attorney Michael DelRossi, filed by Astellas Ireland Co., Ltd., Astellas Pharma Inc., Astellas Pharma Global Development, Inc. ORDERED by Judge Eleanor G. Tennyson on 12/5/2024. Associated Cases: 1:24-cv-00939-JFB-EGT, 1:24-cv-00940-JFB-EGT, 1:24-cv-01068-JFB-EGT, 1:24-cv-01069-JFB-EGT, 1:24-cv-01084-JFB-EGT (lah) (Entered: 12/05/2024) (0) |
| Dec 4, 2024 | 14 | Pro Hac Vice Fee - Credit Card Payment received for Michael DelRossi. ( re 13 MOTION for Pro Hac Vice Appearance of Attorney Michael DelRossi )( Payment of $ 50, receipt number ADEDC-4562592).(Silver, Daniel) (Entered: 12/04/2024) (0) |
| Dec 4, 2024 | 13 | MOTION for Pro Hac Vice Appearance of Attorney Michael DelRossi - filed by Astellas Pharma Inc., Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc.. (Attachments: # 1 Certification for Michael DelRossi)Motions referred to Eleanor G. Tennyson.(Silver, Daniel) (Entered: 12/04/2024) (0) |
| Nov 5, 2024 | N/A | Pro Hac Vice Attorney Diva Hollis for Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., and Astellas Pharma Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:24-cv-00939-JFB-EGT, 1:24-cv-00940-JFB-EGT, 1:24-cv-01068-JFB-EGT, 1:24-cv-01069-JFB-EGT, 1:24-cv-01084-JFB-EGT(cdd) (Entered: 11/05/2024) (0) |
| Nov 5, 2024 | N/A | Pro Hac Vice Attorney James F. Hurst for Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., and Astellas Pharma Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:24-cv-00939-JFB-EGT, 1:24-cv-00940-JFB-EGT, 1:24-cv-01068-JFB-EGT, 1:24-cv-01069-JFB-EGT, 1:24-cv-01084-JFB-EGT(mpb) (Entered: 11/05/2024) (0) |
| Oct 30, 2024 | 12 | Pro Hac Vice Fee - Credit Card Payment received for James F. Hurst, Jeanna M. Wacker, Bryan S. Hales, Ashley Ross, and Diva Hollis. ( re 11 MOTION for Pro Hac Vice Appearance of Attorney James F. Hurst, Jeanna M. Wacker, Bryan S. Hales, Ashley Ross, and Diva Hollis )( Payment of $ 250, receipt number ADEDC-4536657).(Silver, Daniel) (Entered: 10/30/2024) (0) |
| Oct 30, 2024 | N/A | SO ORDERED, re (D.I. 16 in 1:24-cv-01084-JFB-EGT, D.I. 16 in 1:24-cv-00939-JFB-EGT, D.I. 16 in 1:24-cv-00940-JFB-EGT, D.I. 11 in 1:24-cv-01068-JFB-EGT & D.I. 11 in 1:24-cv-01069-JFB-EGT) MOTION for Pro Hac Vice Appearance of Attorney James F. Hurst, Jeanna M. Wacker, Bryan S. Hales, Ashley Ross, and Diva Hollis, filed by Astellas Ireland Co., Ltd., Astellas Pharma Inc., Astellas Pharma Global Development, Inc. ORDERED by Judge Eleanor G. Tennyson on 10/30/2024. (Associated Cases: 1:24-cv-00939-JFB-EGT, 1:24-cv-00940-JFB-EGT, 1:24-cv-01068-JFB-EGT, 1:24-cv-01069-JFB-EGT, 1:24-cv-01084-JFB-EGT) (lah) (Entered: 10/30/2024) (0) |
| Oct 30, 2024 | 11 | MOTION for Pro Hac Vice Appearance of Attorney James F. Hurst, Jeanna M. Wacker, Bryan S. Hales, Ashley Ross, and Diva Hollis - filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Attachments: # 1 Certifications for James F. Hurst, Jeanna M. Wacker, Bryan S. Hales, Ashley Ross, and Diva Hollis)Motions referred to Eleanor G. Tennyson.(Silver, Daniel) (Entered: 10/30/2024) (0) |
| Oct 29, 2024 | N/A | SO ORDERED, re 9 MOTION for Pro Hac Vice Appearance of Attorney Simon D. Roberts, Jason A. Leonard, Vincent Li, and Jayita Guhaniyogi, filed by Astellas Ireland Co., Ltd., Astellas Pharma Inc., Astellas Pharma Global Development, Inc. ORDERED by Judge Eleanor G. Tennyson on 10/29/2024. (lah) (Entered: 10/29/2024) (0) |
| Oct 29, 2024 | 10 | Pro Hac Vice Fee - Credit Card Payment received for Simon D. Roberts, Jason A. Leonard, Vincent Li, and Jayita Guhaniyogi. ( re 9 MOTION for Pro Hac Vice Appearance of Attorney Simon D. Roberts, Jason A. Leonard, Vincent Li, and Jayita Guhaniyogi )( Payment of $ 200, receipt number ADEDC-4535573).(Silver, Daniel) (Entered: 10/29/2024) (0) |
| Oct 29, 2024 | 9 | MOTION for Pro Hac Vice Appearance of Attorney Simon D. Roberts, Jason A. Leonard, Vincent Li, and Jayita Guhaniyogi - filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Attachments: # 1 Certifications for Simon D. Roberts, Jason A. Leonard, Vincent Li, and Jayita Guhaniyogi)Motions referred to Eleanor G. Tennyson.(Silver, Daniel) (Entered: 10/29/2024) (0) |
| Oct 15, 2024 | 8 | ORAL ORDER - Pursuant to the filing of this case, the Court issues the following order: Magistrate Judge Tennyson shall issue a scheduling order when appropriate. Magistrate Judge Tenyson shall handle all nondispositive matters on all issues, except for Daubert motions, Markman hearings, and pretrial motions in limine. The parties have the right to file an appeal of the magistrate judge's order, and the same shall be decided by the undersigned. The magistrate judge shall likewise handle all discovery matters, scheduling, and pretrial conferences. If the parties believe the magistrate judge has a conflict of interest with this case, the parties shall so notify the Court. IT IS SO ORDERED. Signed by Judge Joseph F. Bataillon on 10/15/24. (AEV) (Entered: 10/15/2024) (0) |
| Oct 10, 2024 | 7 | WAIVER OF SERVICE returned executed by Astellas Pharma Inc., Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc.: For Lupin Pharmaceuticals, Inc. waiver sent on 10/8/2024, answer due 12/9/2024. (Silver, Daniel) (Entered: 10/10/2024) (1) |
| Oct 10, 2024 | 6 | WAIVER OF SERVICE returned executed by Astellas Pharma Inc., Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc.: For Lupin Ltd. waiver sent on 10/8/2024, answer due 12/9/2024. (Silver, Daniel) (Entered: 10/10/2024) (1) |
| Oct 2, 2024 | N/A | Case Assigned to Judge Joseph F. Bataillon of the United States District Court for the District of Nebraska, due to related cases. Please include the initials of the Judge (JFB) after the case number on all documents filed. Associated Cases: 1:24-cv-01068-JFB, 1:24-cv-01069-JFB, 1:24-cv-01084-JFB (rjb) (Entered: 10/02/2024) (0) |
| Sep 24, 2024 | 5 | Summons Issued as to Lupin Ltd. on 9/24/2024; Lupin Pharmaceuticals, Inc. on 9/24/2024. (Attachments: # 1 Summons Issued)(mpb) (Entered: 09/25/2024) (0) |
| Sep 24, 2024 | 4 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Astellas Pharma Inc., Corporate Parent Astellas B.V. for Astellas Ireland Co., Ltd.; Corporate Parent Astellas Pharma Inc., Corporate Parent Astellas US Holding, Inc. for Astellas Pharma Global Development, Inc. filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (mpb) (Entered: 09/25/2024) (3) |
| Sep 24, 2024 | 3 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 12,097,189. (mpb) (Entered: 09/25/2024) (1) |
| Sep 24, 2024 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mpb) (Entered: 09/25/2024) (3) |
| Sep 24, 2024 | 1 | Complaint* (1) |
